Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 716,400 | 580,000 | 404,000 | 466,800 | 159,300 |
| Receivables | 1,374,500 | 815,700 | 784,700 | 718,500 | 699,800 |
| Inventories | 191,000 | 139,500 | 136,500 | 121,000 | 110,800 |
| Income taxes - deferred | N/A | 0 | N/A | 10,900 | 10,500 |
| TOTAL | $2,621,200 | $1,692,700 | $1,432,100 | $1,391,800 | $1,060,000 |
| Non-Current Assets | |||||
| PPE Net | 1,747,400 | 786,500 | 707,400 | 630,800 | 578,300 |
| Investments And Advances | 58,200 | 92,600 | 88,500 | 78,100 | 76,800 |
| Intangibles | 9,525,600 | 4,575,200 | 4,594,800 | 4,569,400 | 4,302,500 |
| Other Non-Current Assets | 152,300 | 154,800 | 143,100 | 124,900 | 94,200 |
| TOTAL | $11,483,500 | $5,609,100 | $5,533,800 | $5,403,200 | $5,051,800 |
| Total Assets | $14,104,700 | $7,301,800 | $6,965,900 | $6,795,000 | $6,111,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 497,400 | 282,300 | 304,500 | 236,900 | 257,800 |
| Accrued Expenses | 633,100 | 341,400 | 310,000 | 311,600 | 339,300 |
| TOTAL | $1,700,500 | $976,300 | $735,700 | $1,028,500 | $732,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,940,300 | 2,682,700 | 2,889,100 | 2,175,000 | 2,085,500 |
| Deferred Revenues | 146,100 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 336,900 | 290,500 | 284,300 | 326,400 | 298,900 |
| TOTAL | $7,459,100 | $3,505,000 | $3,738,900 | $3,049,100 | $2,875,700 |
| Total Liabilities | $9,159,600 | $4,481,300 | $4,474,600 | $4,077,600 | $3,608,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,700 | 100,300 | 85,300 | 93,100 | 97,200 |
| Common Shares | 12,000 | 10,400 | 10,500 | 11,300 | 11,700 |
| Retained earnings | 4,223,700 | 3,786,100 | 3,373,500 | 3,588,500 | 3,387,200 |
| Other shareholders' equity | -287,100 | -10,000 | 66,300 | 69,600 | 45,600 |
| TOTAL | $4,945,100 | $2,820,500 | $2,491,300 | $2,717,400 | $2,503,500 |
| Total Liabilities And Equity | $14,104,700 | $7,301,800 | $6,965,900 | $6,795,000 | $6,111,800 |